These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10372797)
1. Inhibitors of cytochrome P450 differentially modify discriminative-stimulus and antinociceptive effects of hydrocodone and hydromorphone in rhesus monkeys. Lelas S; Wegert S; Otton SV; Sellers EM; France CP Drug Alcohol Depend; 1999 May; 54(3):239-49. PubMed ID: 10372797 [TBL] [Abstract][Full Text] [Related]
2. Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in rats. Tomkins DM; Otton SV; Joharchi N; Li NY; Balster RF; Tyndale RF; Sellers EM J Pharmacol Exp Ther; 1997 Mar; 280(3):1374-82. PubMed ID: 9067326 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. Kaplan HL; Busto UE; Baylon GJ; Cheung SW; Otton SV; Somer G; Sellers EM J Pharmacol Exp Ther; 1997 Apr; 281(1):103-8. PubMed ID: 9103485 [TBL] [Abstract][Full Text] [Related]
4. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys. Bowen CA; Fischer BD; Mello NK; Negus SS J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726 [TBL] [Abstract][Full Text] [Related]
5. In vivo activity of norhydrocodone: an active metabolite of hydrocodone. Navani DM; Yoburn BC J Pharmacol Exp Ther; 2013 Nov; 347(2):497-505. PubMed ID: 23995596 [TBL] [Abstract][Full Text] [Related]
6. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Hutchinson MR; Menelaou A; Foster DJ; Coller JK; Somogyi AA Br J Clin Pharmacol; 2004 Mar; 57(3):287-97. PubMed ID: 14998425 [TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys. Gerak LR; Gauthier CR; France CR Psychopharmacology (Berl); 2003 Apr; 166(4):351-9. PubMed ID: 12601499 [TBL] [Abstract][Full Text] [Related]
8. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys. Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513 [TBL] [Abstract][Full Text] [Related]
9. CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Otton SV; Schadel M; Cheung SW; Kaplan HL; Busto UE; Sellers EM Clin Pharmacol Ther; 1993 Nov; 54(5):463-72. PubMed ID: 7693389 [TBL] [Abstract][Full Text] [Related]
10. Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management. Hosseinnejad K; Yin T; Gaskins JT; Stauble ME; Wu Y; Jannetto P; Langman LL; Jortani SA J Appl Lab Med; 2019 May; 3(6):954-964. PubMed ID: 31639687 [TBL] [Abstract][Full Text] [Related]
11. Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing. Linares OA; Fudin J; Daly AL; Boston RC Clin J Pain; 2015 Dec; 31(12):1026-35. PubMed ID: 25621429 [TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of nalbuphine in rhesus monkeys. Gerak LR; France CP J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318 [TBL] [Abstract][Full Text] [Related]
13. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone. Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421 [TBL] [Abstract][Full Text] [Related]
14. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat. Tejwani GA; Rattan AK Anesth Analg; 2002 Jun; 94(6):1542-6, table of contents. PubMed ID: 12032023 [TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. Negus SS; Gatch MB; Mello NK; Zhang X; Rice K J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881 [TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Gatch MB; Negus SS; Mello NK Psychopharmacology (Berl); 1998 Jan; 135(1):99-106. PubMed ID: 9489939 [TBL] [Abstract][Full Text] [Related]